Yaron Barac to Cardiotonic Agents
This is a "connection" page, showing publications Yaron Barac has written about Cardiotonic Agents.
Connection Strength
0.584
-
Barac YD, Bar-Am O, Liani E, Amit T, Frolov L, Ovcharenko E, Angel I, Youdim MB, Binah O. I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline. PLoS One. 2012; 7(11):e47890.
Score: 0.382
-
Malka A, Meerkin D, Barac YD, Malits E, Bachner-Hinenzon N, Carasso S, Ertracht O, Angel I, Shofti R, Youdim M, Abassi Z, Binah O. TVP1022: A Novel Cardioprotective Drug Attenuates Left Ventricular Remodeling After Ischemia/Reperfusion in Pigs. J Cardiovasc Pharmacol. 2015 Aug; 66(2):214-22.
Score: 0.115
-
Abassi ZA, Barac YD, Kostin S, Roguin A, Ovcharenko E, Awad H, Blank A, Bar-Am O, Amit T, Schaper J, Youdim M, Binah O. TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure. Circ Heart Fail. 2011 Jul; 4(4):463-73.
Score: 0.086